bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

hooksAmpRedirectArticle

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

paywallTypes

createdDate

publishedDate

sponsorType

urlAlias

moreOnThisArticles

commentCount

authorLocations

authors

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

articleSpeeches

socialHeadline

headline

images

flag

firstTopic

glossary

flattenTypeIds

image

relatedLinks

relatedNewsletters

__typename

sponsor

pdfFiles

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

readingTime

customTimezone

liveContents

Kinling Lo

China’s decision to join the global initiative for fair distribution of Covid-19 vaccines known as Covax could be a boon for the struggling vaccine project. But what is it and how does it work?
What is Covax?
The Covid-19 Vaccine Global Access (Covax) alliance was launched in April by the World Health Organization (WHO), the European Commission and France as a response to the global health crisis.
It will be implemented by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI) and the public-private partnership Gavi.
According to the WHO it is designed to serve as an “invaluable insurance policy to secure access to safe and effective Covid-19 vaccines”.
Nine CEPI-approved vaccine candidate vaccines are part of the Covax initiative and nine more – two of them Chinese – are under evaluation.
CEPI is an alliance to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics.
Do Chinese Covid-19 vaccines work, and which countries will get them?
Covax aims to deliver at least 2 billion doses of approved vaccines by the end of next year and to ensure “equitable access” to them for all of the countries taking part.
The initiative is also designed to discourage national governments from hoarding vaccines and to prioritise the inoculation of people in high-risk groups in each country.
Gavi described the scheme as an insurance policy for wealthy countries should their own vaccine candidates or deals with foreign suppliers not go to plan.


Which countries are involved?
According to WHO figures, more than 160 countries had signed up for the initiative as of last month, including Australia, Britain, Canada and Japan. The European Commission will procure vaccine doses on behalf of the 27 EU member states and also for Norway and Iceland.
Each nation is classed either as “self-financing” or “funded”. The former are expected to pay for their own doses and contribute to the cost of providing vaccines to the latter, some of which will not have to pay anything at all.

Nations have already contributed US$1.4 billion to pay for research and development but the WHO said last month a further US$700 million to US$800 million was still needed.
Despite widespread international support for the scheme, neither the US nor Russia have joined. They are both working on their own vaccines and pursuing bilateral deals with other countries.
US President Donald Trump earlier accused the WHO of being corrupt and said it helped China, where the coronavirus was first identified, to downplay the scale of the health crisis.
Taiwan and Hong Kong have also signed up for Covax.
Investigation starts into what went right and wrong in Covid-19 response
How will the vaccines be distributed?
Once a Covid-19 vaccine has been shown to be safe and effective, and granted regulatory approval, doses will be allocated to the countries taking part in proportion to their populations.
The first phase of the programme aims to make enough doses available to inoculate 3 per cent of people in each country, which the WHO said would be enough to cover frontline health and social care workers.
Once sufficient numbers of doses are available, each country would receive enough to inoculate up to 20 per cent of their population, and additional doses would be provided to countries where they were considered most needed, it said.


Does China joining Covax change anything?
Beijing did not say exactly how it plans to support the scheme, but said earlier it was in favour of the fair distribution of vaccines around the world.
In May, Chinese President Xi Jinping pledged US$2 billion over two years to support the global response to Covid-19, and Beijing has promised access and financial support to several countries on a bilateral basis.
The WHO said earlier it hoped China and other countries working on vaccine candidates would supply doses for distribution under the scheme.
China is responsible for four of the nine vaccine candidates currently undergoing final stage clinical trials around the world.


Hong Kong’s Peninsula Hotels sees ‘bleisure’ boom after pandemic curbs, CEO says

US could require US$15,000 bonds for some tourist, business visas

China’s Shenzhen, Guangzhou airports hit record highs, surpass pre-Covid passenger levels

Landmark US Chinatown survived Covid, anti-Asian violence – but tariffs pose new threat

Coronavirus pandemic

Covax: China’s in, America’s out, but what is it all about?

The WHO-led Covax alliance aims to make 2 million doses of Covid-19 vaccines available by the end of next year. Photo: Reuters

FILE - In this Sept. 24, 2020, file photo, a worker feeds vials for production of SARS CoV-2 Vaccine for COVID-19 at the SinoVac vaccine factory in Beijing. China said on Friday, Oct. 9, 2020, that it is joining the COVID-19 vaccine alliance known as COVAX. (AP Photo/Ng Han Guan, File)

China joins WHO-led Covax scheme to share coronavirus vaccines fairly

Covax aims to deliver 2 billion doses of a coronavirus vaccine by the end of 2021. Photo: AP

Coronavirus: risk of ADE low with new Chinese vaccine candidate, researchers say

Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images

Do Chinese Covid-19 vaccines work, and which countries will get them?

A vaccine ﻿co-developed by CanSino Biologics is one of four Chinese candidates. Photo: Reuters

News

China

Science

Knowledge

US-China Relations


After saying for some time it wanted to support the global response to Covid-19, Beijing has finally committed to the WHO-led vaccine access alliance
Chinese scientists are involved in the development of several of the products the scheme hopes to distribute fairly around the world



After saying for some time it wanted to support the global response to Covid-19, Beijing has finally committed to the WHO-led vaccine access alliance.


Coronavirus pandemic: All stories

Xi Jinping

Coronavirus China

World Health Organization (WHO)

Disease

Medicine

Provide background, definition and detail of a specific topic, helping the reader understand how something works or what has happened in the past.  (Eg. What is Nafta? US and Mexico are on the verge of revising trade deal.)


Explainer